Paul Reinhard Schimmel (born August 4, 1940) is an American biophysical chemist and translational medicine pioneer.

[4] His research interests have focused on aminoacyl tRNA synthetases as fundamental interpreters of the genetic information.

[5] Through career-long investigations of this ancient and universal set of essential enzymes, his laboratory has worked on a universal mechanism for correcting errors in the interpretation of genetic information,[6][7] and went on to show how this mechanism is essential for maintaining cellular homeostasis and for preventing serious pathologies and disease.

[23] Active in many scientific and academic organizations and committees, including past service as President of the Division of Biological Chemistry of the American Chemical Society (presently with over 7,000 members) and as an editorial board member of numerous scientific journals.

In June 2020, he was named the 2020 winner of the Kathryn C. Hach Award for Entrepreneurial Success for "co-founding more than ten biotech companies and aiding others in their endeavors for nearly three decades.